Fast Facts: CAR T-Cell Therapy in Diffuse Large B-Cell Lymphoma : A Practical Resource for Nurses / Richard J. Buka, Deidre Moloney [electronic resource]
Basel : S. Karger, 2021Description: 1 online resource (94 pages) : 12 figures, 12 in color, 12 tablesISBN:- 9783318069358
| Item type | Home library | Class number | URL | Status | Date due | Barcode | |
|---|---|---|---|---|---|---|---|
| E-book | Bolton NHS Library | Link to resource | Not for loan | ||||
| E-book | Bridgewater Community NHS Library | Link to resource | Not for loan | ||||
| E-book | East Cheshire NHS Library | Link to resource | Not for loan | ||||
| E-book | Greater Manchester Mental Health NHS Library | Link to resource | Not for loan | ||||
| E-book | Lancashire and South Cumbria NHS Library | Link to resource | Not for loan | ||||
| E-book | Lancashire Teaching Hospitals NHS Foundation Trust - Chorley Library | Link to resource | Not for loan | ||||
| E-book | Lancashire Teaching Hospitals NHS Foundation Trust - Preston Library | Link to resource | Not for loan | ||||
| E-book | Liverpool Heart and Chest NHS Library | Link to resource | Not for loan | ||||
| E-book | Liverpool University Hospitals NHS Library (Royal Liverpool) | Link to resource | Not for loan | ||||
| E-book | Liverpool Women’s NHS Library | Link to resource | Not for loan | ||||
| E-book | LKS for NHS Ambulance Services in England (LKS ASE) | Link to resource | Not for loan | ||||
| E-book | Mersey and West Lancashire NHS Library (Southport and Ormskirk) | Link to resource | Not for loan | ||||
| E-book | Mersey and West Lancashire NHS Library (St Helens and Knowsley) | Link to resource | Not for loan | ||||
| E-book | Mid Cheshire NHS Library | Link to resource | Not for loan | ||||
| E-book | Pennine Care NHS Knowledge Service | Link to resource | Not for loan | ||||
| E-book | Tameside and Glossop NHS Library | Link to resource | Not for loan | ||||
| E-book | Wirral NHS Library | Link to resource | Not for loan |
Diffuse large B-cell lymphoma (DLBCL) is the most common form of high-grade non-Hodgkin lymphoma. While treatment with immunochemotherapy has generally shown good outcomes, specific subgroups of patients with high-risk disease have an unfavorable prognosis. Extensive efforts have been made to improve outcomes in these patients. As such, CD19-targeted chimeric antigen receptor (CAR) T-cell therapy has become the new standard of care for patients with relapsed or refractory DLBCL after at least two prior lines of therapy. It is an exciting new therapeutic intervention that is integral to the concept of personalized medicine.
Print version record